🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 00370M103
- IPO
- 10/20/2023 · $11.60/share
- ADR Ratio
- 1:1
Business: iAbivax SA s a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Company Contact
- CEO
- Marc de Garidel
- CFO
- Didier Blondel
- Investor Relations
- Patrick Malloy · 847-987-4878 · https://ir.abivax.com/